North Dakota enacts $25 monthly cap on out-of-pocket insulin costs

North Dakota enacted a $25 monthly cap on patients’ out-of-pocket insulin costs, including for people who have not met their deductibles, in a measure that won bipartisan support. The cap applies to plans regulated by the state, not many self-funded plans offered by large employers, limiting who benefits. The Kritzberger family, whose teenage daughter has Type 1 diabetes, spends at least $8,000 a year on drugs, supplies and appointments; that total is not insulin costs alone and illustrates how the cap does not eliminate the broader financial burden of diabetes care. North Dakota is among 29 states that have adopted insulin-cost caps, amid a growing push for government action on high drug prices.